Governor In Tight Political Spot On Stem Cell Research
By Associated Press,
Associated Press
| 08. 05. 2004
SACRAMENTO, Calif. -- Gov. Arnold Schwarzenegger appears to be in a tight political spot over Proposition 71, a bond measure that would provide $3 billion for human embryonic stem cell research in California.
Support Stem Cell Research?
Should Governor Take Position On Stem Cell Measure?
Schwarzenegger hasn't taken a position on the measure and many analysts believe he won't. That's because no matter which position he endorses, he's sure to alienate important constituents.
The measure promises to be one of the most contentious election issues this year.
It pits Nobel laureates, sympathetic patients who could benefit from stem cells and biotechnology interests against religious groups such as the Roman Catholic Church and political conservatives opposed to the research because it involves destroying days-old embryos and cloning.
Already, Proposition 71 is second only to the two gambling-related measures in campaign fund-raising. Supporters have raised more than $8 million while opponents have eked out less than $50,000.
Schwarzenegger has said he supports the technology. His father-in-law, Sargent Shriver, is in the early grips of Alzheimer's disease, which Proposition 71 supporters say could...
Related Articles
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
